Tavo Biotherapeutics Email Formats
Biotechnology Research • 
United States • 1-10 Employees
Tavo Biotherapeutics Email Formats
Tavo Biotherapeutics uses 2 email formats. The most common is {first initial} (e.g., j@tavobio.com), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@tavobio.com | 60% |
{first name} | john@tavobio.com | 40% |
Key Contacts at Tavo Biotherapeutics
Josh Garlich
Director, Discovery Research
Monica M. Jablonski
Founder And Chief Scientific Officer
Company overview
| Headquarters | United States |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
| Socials |
About Tavo Biotherapeutics
Tavo Biotherapeutics is developing innovative treatments to address critical unmet needs in ophthalmology. TAV-001 engages two novel targets that represent fundamental mechanisms underlying the pathology of glaucoma-related neurodegeneration. In pre-clinical studies, TAV-001 has shown signals of neuroprotection as well as substantial reduction in intraocular pressure, suggesting that it could represent the first disease-modifying pharmaceutical therapy for these patients. TAV-001 is expected to enter a Phase 1 clinical trial in glaucoma patients in 2025. TAV-002 represents a potential first-in-class treatment for retinal disease, including diabetic retinopathy, diabetic macular edema, and both wet and dry age-related macular degeneration. Tavo has initiated IND-enabling activities for this program.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Tavo Biotherapeutics has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
Tavo Biotherapeutics has never raised funding before.
Tavo Biotherapeutics Tech Stack
Discover the technologies and tools that power Tavo Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.
WordPress themes
WordPress plugins
JavaScript libraries
PaaS
Hosting
Reverse proxies
Miscellaneous
Programming languages
Security
Blogs
Databases
Belgium
United Kingdom
Canada
Frequently asked questions
4.8
40,000 users
